Roche Announces Worldwide Availability of Blood-Based Genomic Profiling Test
Liquid biopsy test identifies 70 of the most commonly mutated genes in solid tumors as well as microsatellite instability.
Read More
Search Results for: lung cancer
Asuragen Expands Oncology Portfolio
The panel accurately and sensitively detects more than 1,600 variants of clinical significance.
Read More
Medicare Milestone for Envisia Genomic Classifier
First test for improved IPF diagnosis receives draft local coverage determination through the MolDx program.
Read More
Bio-Rad Launches Anti-Idiotypic Antibodies Targeting Pembrolizumab and Nivolumab
Anti-idiotypic antibodies will enable monitoring of for pembrolizumab and nivolumab levels in cancer patients undergoing treatment.
Read MorePredicting the Effectiveness of Anti-PD-L1 Therapy
A potential alternative to immunohistochemistry for predicting patients’ response to anti-PD-L1 therapy is to use testing based on the droplet digital polymerase chain reaction technique to detect changes in the mRNA expression levels in patients’ blood.
Read More